10 earlier Form 4 trades (code P or S) here by this insider (10 buys), the last on Aug 12, 2025.
-2.0% median (-1.0% mean) 90-day return after 10 previous buys.
The trade is 1.1% of the 174,904 shares held after it.
5 other insiders bought within 30 days.
8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive BROWN JOSEPH W bought about $60.0K of GBLI on Aug 20, 2025; 5 other insiders bought within 30 days and 8 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 100.0% of the 105 shares held after it.
5 other insiders bought within 30 days.
8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Marketing Officer Balderston William V bought about $3.0K of GBLI on Aug 13, 2025; 5 other insiders bought within 30 days and 8 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 100.0% of the 100 shares held after it.
5 other insiders bought within 30 days.
8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Sr. Vice President--HR Reilly Nicole Francois bought about $2.9K of GBLI on Aug 12, 2025; 5 other insiders bought within 30 days and 8 funds added in the latest 13F quarter.
9 earlier Form 4 trades (code P or S) here by this insider (9 buys), the last on Aug 11, 2025.
-2.7% median (-1.9% mean) 90-day return after 9 previous buys.
The trade is 0.3% of the 172,904 shares held after it.
5 other insiders bought within 30 days.
8 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive BROWN JOSEPH W bought about $14.0K of GBLI on Aug 12, 2025; 5 other insiders bought within 30 days and 8 funds added in the latest 13F quarter.
50 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
GBLI planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
GBLI mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Hotchkis and Wiley Small Cap Value Fund
$7.9M position · as of 2026-06-30
1.0%
HW Opportunities MP Fund
$453.9K position · as of 2026-06-30
0.6%
Boston Partners Small Cap Value Fund II
$2.9M position · as of 2026-05-31
0.4%
Columbia Small Cap Value Discovery Fund
$7.4M position · as of 2026-07-31
0.3%
Hotchkis & Wiley Opportunities Fund
$2.6M position · as of 2026-06-30
0.3%
Columbia Variable Portfolio - Small Cap Value Discovery Fund
$1.2M position · as of 2026-06-30
0.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Joseph W.Brown
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$4.1M
$3.1M
$821.7K
+38%
+79%
2023
$3.0M
$4.0M
$596.6K
+24%
+44%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 8 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$456.2M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM GBLI
FY Dec 2025
$450.1M
FY Dec 2024
$441.2M
FY Dec 2023
$528.1M
FY Dec 2022
$628.5M
FY Dec 2021
$678.3M
Jun 2026
$116.1M
Mar 2026
$109.2M
Dec 2025
$116.7M
Sep 2025
$114.2M
Jun 2025
$110.5M
Mar 2025
$108.7M
Dec 2024
$108.4M
Sep 2024
$111.8M
At each fiscal year end
Single quarter
Net margin, TTM
+7.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM GBLI
FY Dec 2025
+5.6%
FY Dec 2024
+9.8%
FY Dec 2023
+4.8%
FY Dec 2022
-0.1%
FY Dec 2021
+4.3%
Jun 2026
+9.5%
Mar 2026
+3.9%
Dec 2025
+5.5%
Sep 2025
+11.0%
Jun 2025
+9.4%
Mar 2025
-3.7%
Dec 2024
+8.3%
Sep 2024
+11.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM GBLI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term debt only, 2022-12-31 (42 months older than the period end); equity 2026-06-30
Debt to equity GBLI
FY Dec 2025
0.00x
FY Dec 2024
0.00x
FY Dec 2023
0.00x
FY Dec 2022
0.00x
FY Dec 2021
0.18x
Jun 2026
0.00x
Mar 2026
0.00x
Dec 2025
0.00x
Sep 2025
0.00x
Jun 2025
0.00x
Mar 2025
0.00x
Dec 2024
0.00x
Sep 2024
0.00x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt to cover
Cash flow to debt GBLI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
0.72x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+4.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity GBLI
FY Dec 2025
+3.6%
FY Dec 2024
+6.5%
FY Dec 2023
+4.0%
FY Dec 2022
-0.1%
FY Dec 2021
+4.1%
Jun 2026
+4.9%
Mar 2026
+4.8%
Dec 2025
+3.6%
Sep 2025
+4.0%
Jun 2025
+4.1%
Mar 2025
+4.1%
Dec 2024
+6.5%
Sep 2024
+6.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets GBLI
FY Dec 2025
+1.5%
FY Dec 2024
+2.5%
FY Dec 2023
+1.4%
FY Dec 2022
-0.0%
FY Dec 2021
+1.5%
Jun 2026
+2.0%
Mar 2026
+2.0%
Dec 2025
+1.5%
Sep 2025
+1.6%
Jun 2025
+1.6%
Mar 2025
+1.6%
Dec 2024
+2.5%
Sep 2024
+2.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital GBLI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed GBLI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.79x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing GBLI
FY Dec 2025
16.50x
FY Dec 2024
11.58x
FY Dec 2023
17.62x
FY Dec 2022
n/a
FY Dec 2021
12.76x
Jun 2026
10.61x
Mar 2026
11.79x
Dec 2025
16.50x
Sep 2025
15.21x
Jun 2025
15.92x
Mar 2025
17.31x
Dec 2024
11.58x
Sep 2024
11.42x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value GBLI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield GBLI
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.54x
P/E over trailing EPS growth of 20%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing GBLI
FY Dec 2025
n/a
FY Dec 2024
0.17x
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
0.54x
Mar 2026
0.73x
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
0.17x
Sep 2024
0.13x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
GBLI ranks highest on financial health (99th percentile) and risk and compliance (69th), and lowest on institutional and government (7th), among Insurance peers.
Profitability
29
Inputs
Return on equity+4.9% · 17 pct, sector of 116
Return on assets+2.0% · 40 pct, sector of 122
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 104
Cash flow to debtno debt to cover
Growth
26
Inputs
Revenue growth, YoY+2.0% · 26 pct, sector of 134
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
7
Inputs
Funds adding, latest quarter8 · 7 pct, sector of 108
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
69
Inputs
Short interest, % of float+0.1% · 96 pct, sector of 138
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+11.4% · 43 pct, sector of 110
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.